The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125279591 12527959 1 I 20160623 20160705 20160705 EXP NL-TEVA-673908ISR TEVA VAN AALST J, TEERNSTRA OP, WEBER WE, RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL. 2016; 9:117-120 63.00 YR F Y 0.00000 20160705 MD NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125279591 12527959 1 PS MORPHINE MORPHINE 1 Intrathecal 3.5 MILLIGRAM DAILY; Y 202718
125279591 12527959 2 SS MORPHINE MORPHINE 1 Intrathecal WEAN FROM THE DRUG WITH STEPS OF 0.5MG/DAY Y 202718
125279591 12527959 3 SS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 1200 MILLIGRAM DAILY; Y 63027 300 MG QID
125279591 12527959 4 SS AMITRIPTYLINE AMITRIPTYLINE 1 25 MILLIGRAM DAILY; Y 0 QD
125279591 12527959 5 SS AMITRIPTYLINE AMITRIPTYLINE 1 10 MILLIGRAM DAILY; Y 0
125279591 12527959 6 SS AMOXICILLIN W/CLAVULANIC ACID AMOXICILLINCLAVULANIC ACID 1 4 DOSAGE FORMS DAILY; Y 65096 1 DF QID
125279591 12527959 7 SS DIAZEPAM. DIAZEPAM 1 Oral 15 MILLIGRAM DAILY; Y 70152 5 MG TID
125279591 12527959 8 SS DUROGESIC FENTANYL 1 Transdermal 100 MICROGRAM/HOUR Y 20747
125279591 12527959 9 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 80 MILLIGRAM DAILY; Y 0 20 MG QID
125279591 12527959 10 SS AMOXICILLIN W/CLAVULANIC ACID AMOXICILLINCLAVULANIC ACID 1 Intravenous (not otherwise specified) Y 65096 QID
125279591 12527959 11 SS CLONIDINE. CLONIDINE 1 Oral .45 MILLIGRAM DAILY; Y 0 .15 MG TID
125279591 12527959 12 C PROPOFOL. PROPOFOL 1 Y 0
125279591 12527959 13 C SUFENTANIL SUFENTANIL 1 Y 0
125279591 12527959 14 C ROCURONIUM ROCURONIUM BROMIDE 1 Y 0
125279591 12527959 15 C SEVOFLURANE. SEVOFLURANE 1 Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125279591 12527959 1 Amputation stump pain
125279591 12527959 2 Amputation stump pain
125279591 12527959 4 Amputation stump pain
125279591 12527959 5 Amputation stump pain
125279591 12527959 7 Muscle spasms
125279591 12527959 8 Pain
125279591 12527959 9 Pain
125279591 12527959 11 Pain
125279591 12527959 12 General anaesthesia
125279591 12527959 13 General anaesthesia
125279591 12527959 14 General anaesthesia
125279591 12527959 15 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
125279591 12527959 OT
125279591 12527959 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125279591 12527959 Drug withdrawal syndrome
125279591 12527959 Hemiparesis
125279591 12527959 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found